2 6-MONTH SUSTAINED-RELEASE DEPOTS OF AVORELIN, A NEW LHRH AGONIST - PRELIMINARY ENDOCRINOLOGIC AND PHARMACOKINETIC RESULTS IN PROSTATE-CANCER PATIENTS
Av. Kaisary et al., 2 6-MONTH SUSTAINED-RELEASE DEPOTS OF AVORELIN, A NEW LHRH AGONIST - PRELIMINARY ENDOCRINOLOGIC AND PHARMACOKINETIC RESULTS IN PROSTATE-CANCER PATIENTS, The Journal of urology, 159(5), 1998, pp. 1299-1299